Answers are grounded in this paper and cite their sources.
UDCA treatment alleviates symptoms and improves outcomes in intrahepatic cholestasis of pregnancy, suggesting effective care strategies.
UDCA treatment effectively alleviated these abnormalities, improved symptoms like pruritus and enhanced outcomes for both mother and fetus. The findings advocate for UDCA's safety and efficacy in treating IHCP and emphasize the need for early diagnosis and biochemical monitoring to optimize care and reduce complications.
No takes yet. Share an insight, caveat, or question.
Patel et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: